Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Cash Flow Reinvestment Rate
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥26.90 Million (capex CN¥26.90 Million ) from operating cash flow of CN¥133.43 Million. Explore 600572 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Also explore 600572 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Zhejiang CONBA Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600572 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥203.16 Million | CN¥942.61 Million | CN¥147.26 Million | ▼ -37.5% |
| 2024 | 0.34x | CN¥349.14 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -9.3% |
| 2023 | 0.38x | CN¥341.77 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +13.9% |
| 2022 | 0.33x | CN¥385.99 Million | CN¥1.16 Billion | CN¥291.75 Million | ▼ -59.7% |
| 2021 | 0.83x | CN¥736.86 Million | CN¥889.94 Million | CN¥568.37 Million | ▲ +40.6% |
| 2020 | 0.59x | CN¥736.05 Million | CN¥1.25 Billion | CN¥460.40 Million | ▲ +19.8% |
| 2019 | 0.49x | CN¥454.84 Million | CN¥925.50 Million | CN¥268.79 Million | ▼ -83.6% |
| 2018 | 3.00x | CN¥1.64 Billion | CN¥545.78 Million | CN¥379.63 Million | ▲ +451.1% |
| 2017 | 0.54x | CN¥387.93 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -39.6% |
| 2016 | 0.90x | CN¥874.41 Million | CN¥969.71 Million | CN¥231.83 Million | ▼ -32.0% |
| 2015 | 1.33x | CN¥1.10 Billion | CN¥831.26 Million | CN¥286.97 Million | ▲ +90.7% |
| 2014 | 0.70x | CN¥429.23 Million | CN¥617.43 Million | CN¥429.23 Million | ▼ -65.7% |
| 2013 | 2.02x | CN¥476.32 Million | CN¥235.36 Million | CN¥476.32 Million | ▲ +107.4% |
| 2012 | 0.98x | CN¥239.76 Million | CN¥245.76 Million | CN¥239.76 Million | ▲ +38.1% |
| 2011 | 0.71x | CN¥133.09 Million | CN¥188.36 Million | CN¥133.09 Million | ▼ -21.3% |
| 2010 | 0.90x | CN¥113.07 Million | CN¥125.93 Million | CN¥113.07 Million | ▲ +158.3% |
| 2009 | 0.35x | CN¥53.32 Million | CN¥153.39 Million | CN¥53.32 Million | ▼ -57.8% |
| 2008 | 0.82x | CN¥81.12 Million | CN¥98.56 Million | CN¥81.12 Million | ▼ -19.5% |
| 2007 | 1.02x | CN¥81.83 Million | CN¥79.98 Million | CN¥81.83 Million | ▲ +10.9% |
| 2006 | 0.92x | CN¥65.67 Million | CN¥71.20 Million | CN¥65.67 Million | ▼ -6.9% |
| 2005 | 0.99x | CN¥116.57 Million | CN¥117.65 Million | CN¥116.57 Million | ▲ +1.7% |
| 2004 | 0.97x | CN¥63.81 Million | CN¥65.47 Million | CN¥63.81 Million | ▲ +61.0% |
| 2003 | 0.61x | CN¥40.34 Million | CN¥66.64 Million | CN¥40.34 Million | — |